Structure and conformational dynamics of the sodium/proline transporter PutP based on protein chemical and EPR spectroscopic analyses  by Hilger, D. et al.
4P3
Thiazolidinediones inhibit the transport activity of the
mitochondrial pyruvate carrier proteins MPC-1 and MPC-2
Ajit S. Divakaruni1, Sandra E. Wiley1, Alexander Y. Andreyev1,
George W. Rogers2, William G. McDonald3,
Jerry R. Colca3, Anne N. Murphy1
1Department of Pharmacology, University of California,
San Diego School of Medicine, La Jolla, CA 92093, USA
2Seahorse Bioscience, North Billerica, MA 01862, USA
3Metabolic Solutions Development Company, Kalamazoo, MI 49007, USA
E-mail: adivakaruni@ucsd.edu
MPC-1 and MPC-2 were recently identiﬁed as essential compo-
nents of the mitochondrial pyruvate transporter [1,2]. Here we report
that thiazolidinediones (TZDs), which promote insulin sensitization
in human skeletal muscle and increase the capacity to oxidize fatty
acids, are acute inhibitors of pyruvate transport.
As PPAR-γ agonists, TZDs can also causemarked side effects that can
be clinically prohibitive, such as plasma volume expansion, increased
adiposity, congestive heart failure, and cardiovascular risk. Existing
TZDs (rosiglitazone and troglitazone) and a prototype, PPAR-γ-sparing
compound (MSDC-0160) selectively inhibit pyruvate oxidation in
permeabilized rodent myocytes (primary and immortalized cultures)
and patient-derived, permeabilized skeletal muscle myocytes.
Clinically relevant drug concentrations (1 μMbKdb9 μM) selec-
tively inhibit pyruvate-driven respiration, but have no effect on
oxidation of other complex I-linked substrates or succinate. More-
over, the respiratory inhibition can be rescued upon addition of
methyl pyruvate, indicating that pyruvate dehydrogenase activity is
unaffected.
Permeabilized C2C12 myoblasts show signiﬁcantly compromised
pyruvate-driven respiration upon shRNA knockdown of either MPC-1
or MPC-2. No respiratory defect is observed on a variety of other
substrates, and the respiratory rate can be signiﬁcantly restored with
methyl pyruvate.
Furthermore, acute knockdown of either MPC-1 or MPC-2 left-shifts
the dose–response curve for both TZDs and the highly speciﬁc MPC
inhibitor UK5099, indicating that the MPC complex is indeed a target of
modulation by TZDs. Experiments to determine themechanism bywhich
pyruvate transport relates to insulin-sensitization are underway.
In summary, these results provide two principal observations:
(1) a rigorous, biochemical validation ofMPC-1 andMPC-2 as obligatory
components of themitochondrial pyruvate transporter, and (2) the ﬁrst
demonstration that TZDs acutely inhibit pyruvate transport at clinically
relevant concentrations.
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Mitochondria import a plethora of proteins into four distinct com-
partments, via complex and versatile networks of dynamic targeting
pathways. Due to an intense biochemical effort our mechanistic
knowledge has advanced signiﬁcantly, yet there is a paucity of
structural information and our understanding is incomplete. We aim
to address this void by capture of an electron dense pre-protein
through both mitochondrial TOM/TIM23 complexes concurrently.
Electron cryo-tomography is being used to determine the three
dimensional organisation of translocation sites in situ.
A novel translocation substrate has been designed, consisting of
an N-terminal mitochondrial targeting presequence (pre-cytochrome
b2), followed by a section with the ability to fold and trap the
protein in the membrane (dihydrofolate reductase) and a C-terminal
electron dense tag to enable visualisation in the microscope
(methallothionein). The substrate has been determined to be functional
by in vitro transcription/translation methods with energised mito-
chondria and downstream protease protection. Formation of the
TOM/TIM23 supercomplex has also been veriﬁed by native-PAGE.
Subsequently, overexpression of the protein has been optimised in
Escherichia coli and labeling procedures have been established in
order to tag the protein with gold. To ensure that the tag can be
visualised, electron cryo-tomography has been used to view the
protein in solution. Mitochondria have been isolated from the yeast
Saccharomyces cerevisae and tomograms were collected at a resolu-
tion to reveal internal molecular detail. Preliminary data is now being
collected of mitochondria in the presence of the gold-labeled sub-
strate. We aim to localise the import complexes on the mitochondrial
surface and ultimately perform subtomogram averaging. By capture
of a pre-protein in the act of import, fundamental structural infor-
mation regarding the supramolecular organisation of the TOM/TIM
supercomplex will be obtained.
In order to render mitochondrial import sites visible, an electron
dense translocation substrate has been stalled across inner and outer
membranes concurrently. This unique protein is both functional for
import and arrest and can be seen in the microscope, demonstrating
the value of such tools for in situ analysis of cellular mechanisms.
doi:10.1016/j.bbabio.2012.06.102
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The sodium/proline symporter PutP is a member of the sodium/
substrate symporter family (SSSF), which comprises more than 400
proteins of all three branches of the phylogenetic tree of life. PutP
catalyzes the coupled translocation of sodium ions and proline with
a stoichiometry of 1:1. It is employed by bacteria and archaea to
accumulate proline as a nutrient or compatible solute under osmotic
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stress conditions [1]. The transporter contributes to virulence of
pathogens such as Staphylococcus aureus and Helicobacter pylori. We
utilize PutP of Escherichia coli as a model to explore structure and
molecular mechanism of function of SSSF proteins.
Here, we present a model of the helix bundle of PutP obtained by
molecular modeling constrained by experimentally determined intra-
molecular distances and template restraints derived from the ten-
helix core of the vSGLT crystal structure [2]. For this purpose, DEER
distance measurements between spin labels attached to helix ends
were conducted and mean interspin distances were determined.
Fitting algorithm based on matrix geometry in combination with
prediction of spin label conformations by a rotamer library approach
[3] resulted in an ensemble of helix bundle structures. The central
structure of the ensemble showed a core structure with a fold similar
to that of the vSGLT template. Furthermore, analysis of spin label
motility and environmental polarity by cwEPR yielded information
on secondary structure elements and structural rearrangements of
external loop (eL) 9 of PutP upon sodium and/or l-proline binding.
The results support the idea that eL9 controls access to the sodium
and/or l-proline binding site(s) similar as previously proposed for eL
4 of LeuT [4].
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To date eleven disorders are known to be caused by defects of mito-
chondrial carriers, a family of proteins that shuttle a variety ofmetabolites
across the inner mitochondrial membrane. Mutations of mitochondrial
carrier genes are responsible for carnitine/acylcarnitine carrier deﬁcien-
cy, ornithine carrier deﬁciency (HHH syndrome), aspartate/glutamate
isoform 1 deﬁciency (global cerebral hypomyelination), aspartate/
glutamate isoform 2 deﬁciency (CTLN2 andNICCD), Amishmicrocephaly,
early epileptic encephalopathy, congenital sideroblastic anemia, PiC deﬁ-
ciency, ADP/ATP carrier isoform 1 deﬁciency, neuropathy with bilateral
striatal necrosis and adPEO (autosomal dominant progressive external
ophthalmoplegia). Structural, functional and bioinformatics studies have
revealed the existence in mitochondrial carriers of a substrate-binding
site in the internal carrier cavity, of two gates that close the cavity
alternatively on the matrix or cytosolic side of themembrane, and of two
sets of prolines and glycines in the six transmembrane a-helices located
strategically between the substrate-binding site and the two gates. The
key role played by these mitochondrial carrier areas is supported by
the observation that they host most of the disease-causing missense
mutations of the mitochondrial carriers.
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Na+/Ca2+ exchangers (NCX) and potassium-dependent Na+/
Ca2+ exchangers (NCKX) are two related families of transporters
involved in Ca2+ signaling that function by extruding cytosolic Ca2+
(and K+ for the potassium-dependent transporter) in exchange for
extracellular Na+ [1]. Previous studies have established that this
exchange process is electrogenic and with a deﬁned stoichiometry,
and have identiﬁed speciﬁc acidic aminoacids believed to be crucial
for ion binding and translocation [1–3]. Recently the crystal structure
of the NCX from Methanococcus jannaschii was determined at 1.9 Å
resolution [4], revealing an intriguing transmembrane topology
consisting of inverted structural repeats, and the presence of four
putative ion binding sites formed by highly conserved residues.
Notwithstanding these groundbreaking insights, based on the struc-
ture alone several ion occupancy states can be hypothesized that
would be compatible with the experimental exchange stoichiometry.
Moreover, in the crystal the protein adopts a unique outward facing
conformation, which does not immediately explain how ion binding
to the protein facilitates the necessary outward-to-inward conforma-
tional transition. Here, we use extensive molecular simulations and
molecular modeling to investigate the occupancy and speciﬁcity of
the ion binding sites in NCX_Mj, and the microscopic mechanism by
which Na+ and Ca2+ are exchanged across the membrane.
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